share_log

Aytu BioPharma analyst ratings

Aytu BioPharma analyst ratings

Aytu BioPharma分析师评级
Benzinga Analyst Ratings ·  2022/04/28 18:59
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
04/28/2022 1688.62% HC Wainwright & Co. $24 → $11 Maintains Buy
03/30/2021 1688.62% Cantor Fitzgerald → $11 Initiates Coverage On → Overweight
05/29/2020 387.8% HC Wainwright & Co. → $3 Initiates Coverage On → Buy
10/22/2018 1526.02% Northland Capital Markets → $10 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
04/28/2022 1688.62% HC Wainwright公司 $24 → $11 维护
03/30/2021 1688.62% 康托·菲茨杰拉德 → $11 开始承保 →超重
05/29/2020 387.8% HC Wainwright公司 → $3 开始承保 →购买
10/22/2018 1526.02% 北国资本市场 → $10 开始承保 →跑赢大盘
Data brought to you by Benzinga APIs
Benzinga API为您带来的数据

Aytu BioPharma Questions & Answers

Aytu BioPharma问答

What is the target price for Aytu BioPharma (AYTU)?
Aytu BioPharma(AYTU)的目标价是多少?

The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by HC Wainwright & Co. on April 28, 2022. The analyst firm set a price target for $11.00 expecting AYTU to rise to within 12 months (a possible 1688.62% upside). 1 analyst firms have reported ratings in the last year.

爱图生物制药(纳斯达克:AYTU)的最新目标价是由HC Wainwright&Co.于2022年4月28日报道的。这家分析公司将目标价定为11美元,预计AYTU将在12个月内上涨至(可能上涨1688.62%)。1家分析公司在过去一年公布了评级。

What is the most recent analyst rating for Aytu BioPharma (AYTU)?
Aytu BioPharma(AYTU)的最新分析师评级是多少?

The latest analyst rating for Aytu BioPharma (NASDAQ: AYTU) was provided by HC Wainwright & Co., and Aytu BioPharma maintained their buy rating.

纳斯达克(Sequoia Capital:AYTU)的最新分析师评级由HC Wainwright&Co.提供,Aytu BioPharma维持买入评级。

When is the next analyst rating going to be posted or updated for Aytu BioPharma (AYTU)?
Aytu BioPharma(AYTU)的下一次分析师评级将于何时发布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aytu BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aytu BioPharma was filed on April 28, 2022 so you should expect the next rating to be made available sometime around April 28, 2023.

分析师在进行了广泛的研究后得出了股票评级,其中包括查看公开的财务报表,与Aytu BioPharma的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Aytu BioPharma的上一次评级是在2022年4月28日提交的,所以你应该预计下一次评级将在2023年4月28日左右的某个时候提供。

Is the Analyst Rating Aytu BioPharma (AYTU) correct?
分析师对Aytu BioPharma(AYTU)的评级正确吗?

While ratings are subjective and will change, the latest Aytu BioPharma (AYTU) rating was a maintained with a price target of $24.00 to $11.00. The current price Aytu BioPharma (AYTU) is trading at is $0.62, which is out of the analyst's predicted range.

虽然评级是主观的,并将发生变化,但最新的Aytu BioPharma(AYTU)评级维持不变,目标价在24.00美元至11.00美元之间。Aytu BioPharma目前的股价为0.62美元,超出了分析师的预期区间。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发